Every method? No, that just wastes money.

Standard practice is to have a "target product profile" which guides development. The mode of delivery is typically established in advance. Since clinical studies are very expensive, it is normal to initially focus on one method of delivery. After initial market introduction, additional methods could be added to expand the market.